ABBV
AbbVie Inc
NYSE: ABBV · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$211.32
+3.64% today
Updated 2026-04-30
Market cap
$360.63B
P/E ratio
99.95
P/S ratio
5.90x
EPS (TTM)
$2.04
Dividend yield
—
52W range
$171 – $239
Volume
7.0M
AbbVie Inc (ABBV) Financial statements
SEC filings — annual and quarterly data.
Profit margin
6.91%
Operating margin
34.10%
ROE
62.30%
ROA
9.81%
Debt/equity
-21.06x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2009 | $14.21B | $4.64B | 71.46% | 34.70% | 32.62% |
| 2010 | $15.64B | $4.18B | 72.55% | 30.16% | 26.72% |
| 2011 | $17.44B | $3.43B | 73.41% | 20.75% | 19.68% |
| 2012 | $18.38B | $5.28B | 75.47% | 31.65% | 28.70% |
| 2013 | $18.79B | $4.13B | 75.62% | 30.14% | 21.97% |
| 2014 | $19.96B | $1.77B | 77.83% | 17.09% | 8.89% |
| 2015 | $22.86B | $5.14B | 80.31% | 32.97% | 22.50% |
| 2016 | $25.64B | $5.95B | 77.25% | 36.43% | 23.22% |
| 2017 | $28.22B | $5.31B | 75.05% | 33.83% | 18.82% |
| 2018 | $32.75B | $5.69B | 76.44% | 19.49% | 17.36% |
| 2019 | $33.27B | $7.88B | 77.64% | 39.03% | 23.69% |
| 2020 | $45.80B | $4.62B | 66.41% | 24.81% | 10.08% |
| 2021 | $56.20B | $11.54B | 68.96% | 31.89% | 20.54% |
| 2022 | $58.05B | $11.84B | 70.00% | 31.21% | 20.39% |
| 2023 | $54.32B | $4.86B | 62.42% | 23.49% | 8.95% |
| 2024 | $56.33B | $4.28B | 69.99% | 16.22% | 7.59% |
| 2025 | $61.16B | $4.23B | 70.24% | 32.85% | 6.91% |